| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARDX | Common Stock | Options Exercise | $4,050 | +7,500 | +6% | $0.5400* | 131,551 | 15 Jun 2021 | Direct | F1 |
| transaction | ARDX | Common Stock | Sale | $54,658 | -7,500 | -5.7% | $7.29 | 124,051 | 15 Jun 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARDX | Stock Option (Right to Buy) | Options Exercise | $0 | -7,500 | -43% | $0.000000 | 10,000 | 15 Jun 2021 | Common Stock | 7,500 | $0.5400 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. |
| F2 | This transaction was executed in multiple trades in prices ranging from $7.242 to $7.41, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F3 | The option, which was granted on August 11, 2011 and has an expiration date of August 11, 2021, is fully vested and exercisable. |